ELI LILLY & Co 8-K

What Happened
Eli Lilly and Company (LLY) filed a Form 8‑K with the SEC on February 4, 2026 (Accession No. 0000059478-26-000008) to report results of operations and financial condition under Item 2.02. The company furnished a press release dated February 4, 2026 as Exhibit 99.1; the filing also includes the interactive XBRL cover page (Exhibit 104). The report was signed by Donald A. Zakrowski, Senior Vice President, Finance, and Chief Accounting Officer, on February 4, 2026.

Key Details

• Filing date: February 4, 2026 (Form 8‑K, Accession No. 0000059478-26-000008).
• Item reported: 2.02 — Results of Operations and Financial Condition.
• Exhibit 99.1: Press release of Eli Lilly and Company dated February 4, 2026 (furnished).
• Exhibit 104: Cover Page Interactive Data File (iXBRL) included; filing signed by Donald A. Zakrowski.

Why It Matters
This 8‑K indicates Eli Lilly furnished updated financial or operational results to the market; investors should review the attached press release (Exhibit 99.1) for the specific earnings, revenue, or guidance details. Timely disclosures under Item 2.02 can affect short‑term trading and inform longer‑term valuation decisions, so retail investors should read the press release and any related earnings materials before making investment choices.